C6orf52

Model summary

A soluble human adaptor that shuttles between cytoplasm and nucleus to coordinate RNA-centered assemblies with transcriptional control. It likely operates as a scaffold that binds multiple partners to stabilize cytosolic complexes involved in specialized tRNA pathways and, upon nuclear entry, assembles repressive modules that dampen gene output. By coupling cytoplasmic RNA handling with nucleoplasmic repression, it fine-tunes cellular programs through regulated protein–protein interactions rather than direct catalysis.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   The polypeptide is fully encompassed by IPR040434 (tRNA selenocysteine 1-associated protein 1 family, residues 1–148), indicating a conserved, non-enzymatic family specialized for RNA-associated pathways. Nested within this, IPR041085 (tRNA selenocysteine 1-associated protein 1, C-terminal domain, residues 16–147) defines a structured C-terminal core that likely mediates macromolecular interactions. The arrangement—an N-to-C continuous family signature capped by a defined C-terminal interaction module—argues for a soluble adaptor/scaffold rather than a catalytic enzyme. Such scaffolds typically exert function through multivalent contacts, which causally supports GO:0005515 protein binding as the primary molecular function.

2. 02

   From this scaffolded architecture, I infer function in RNA-centered pathways.

   The explicit association with tRNA selenocysteine pathways suggests a role in organizing or stabilizing assemblies that handle specialized tRNA-derived products or RNA processing steps. The absence of catalytic motifs and the presence of a conserved interaction domain point to a mechanism that modulates other macromolecules’ activities rather than directly transforming substrates. This adaptor role can extend to transcriptional control: scaffolds that shuttle between RNA processing and chromatin-associated complexes often tune gene output by sequestering or recruiting transcriptional regulators. This provides a mechanistic route to GO:0045892 negative regulation of DNA-templated transcription—by assembling repressive complexes or limiting activator access in the nucleus.

3. 03

   Cellular localization follows from solubility and shuttling behavior.

   The lack of transmembrane features and the adaptor-like fold place the protein in soluble compartments. Its operational hubs are the GO:0005829 cytosol and GO:0005654 nucleoplasm, consistent with a shuttling factor that coordinates cytoplasmic RNA/selenoprotein-related assemblies with nuclear transcriptional machinery. This dual residency explains how it can both chaperone tRNA-associated complexes in the cytosol and participate in transcriptional repression within the nucleoplasm.

4. 04

   Integrating these lines, I propose a mechanism: the C-terminal domain (IPR041085) forms a binding platform that nucleates transient complexes.

   In the cytosol, it likely stabilizes assemblies related to selenocysteine-tRNA handling and broader RNA maturation. Upon nuclear entry, the same interaction surface recruits transcriptional repressors or chromatin remodelers to dampen gene expression, aligning with negative regulation of transcription. Likely interaction partners include RNA-centric assemblies and transcriptional modulators; candidates include components of the RNA polymerase II regulatory axis and chromatin-associated repressors, as well as cytosolic RNA-binding factors that coordinate tRNA-derived pathways. This shuttling scaffold thereby couples cytoplasmic RNA/selenoprotein-related processes to nuclear repression circuits to fine-tune cellular gene expression programs.